A Revolution in the Treatment of Obesity.
Am J Med · 2024
Last updated 2026-05-28Up to 40% of Americans are obese and 20% are overweight, and until recently, weight loss options were limited. A new class of drugs called incretins has been developed, leading to weight loss of about 20 to 25% of body weight in obese patients.
AI summary of the abstract below.
| Journal | Am J Med, 2024 |
|---|---|
| Citations | 4 |
| Relative citation ratio | 0.90 |
| NIH percentile | 47 |
| Molecules | — |
| Conditions studied | Obesity |
Abstract
Forty percent of Americans are obese and 20% are overweight. Until recently, notwithstanding great efforts to combat this chronic, worsening epidemic, the only therapy that "worked" was surgery. However, recently, a new class of safe drugs (incretins) have been developed that cause obese patients to lose ∼20 to 25% of their body weight. Herein we recount this revolution and its implications.
Verbatim abstract via PubMed 38788825 ↗